SARS-CoV-2 Vaccines: Status Report

Agostini, 2018, Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease, MBio, 9, 10.1128/mBio.00221-18 Agrawal, 2016, Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus, Hum. Vaccin. Immunother., 12, 2351, 10.1080/21645515.2016.1177688 Bao, 2020, The Pathogenicity of 2019 Novel Coronavirus in hACE2 Transgenic Mice, bioRxiv Benoit, 2015, Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease, Open Forum Infect. Dis., 2, ofv067, 10.1093/ofid/ofv067 Bolles, 2011, A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge, J. Virol., 85, 12201, 10.1128/JVI.06048-11 Brown, 2019, Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase, Antiviral Res., 169, 104541, 10.1016/j.antiviral.2019.104541 Callow, 1990, The time course of the immune response to experimental coronavirus infection of man, Epidemiol. Infect., 105, 435, 10.1017/S0950268800048019 Chan, 2015, Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset, J. Infect. Dis., 212, 1904, 10.1093/infdis/jiv392 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Choe, 2017, MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015, Emerg. Infect. Dis., 23, 1079, 10.3201/eid2307.170310 Chu, 2004, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658 Cui, 2019, Origin and evolution of pathogenic coronaviruses, Nat. Rev. Microbiol., 17, 181, 10.1038/s41579-018-0118-9 de Wit, 2020, Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection, Proc. Natl. Acad. Sci. USA, 10.1073/pnas.1922083117 DiazGranados, 2013, High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009–2010 season, Vaccine, 31, 861, 10.1016/j.vaccine.2012.12.013 Erbelding, 2018, A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases, J. Infect. Dis., 218, 347, 10.1093/infdis/jiy103 Fehr, 2015, Coronaviruses: an overview of their replication and pathogenesis, Methods Mol. Biol., 1282, 1, 10.1007/978-1-4939-2438-7_1 Gorbalenya, 2020, The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, Nat. Microbiol. Guan, 2020, Clinical characteristics of 2019 novel coronavirus infection in China, N. Engl. J. Med., 10.1056/NEJMoa2002032 Holshue, 2020, First Case of 2019 Novel Coronavirus in the United States, N. Engl. J. Med., 382, 929, 10.1056/NEJMoa2001191 Houser, 2017, Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody, PLoS Pathog., 13, e1006565, 10.1371/journal.ppat.1006565 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Hull, 2011, Ritonavir-boosted protease inhibitors in HIV therapy, Ann. Med., 43, 375, 10.3109/07853890.2011.572905 Johnson and Johnson, 2020 Kadam, 2017, Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol, Proc. Natl. Acad. Sci. USA, 114, 206, 10.1073/pnas.1617020114 Krammer, 2015, Advances in the development of influenza virus vaccines, Nat. Rev. Drug Discov., 14, 167, 10.1038/nrd4529 Lam, 2020, Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China, bioRxiv Lan, 2020, Crystal structure of the 2019-nCoV spike receptor-binding domain bound with the ACE2 receptor, bioRxiv Lan, 2020, Positive RT-PCR Test Results in Patients Recovered From COVID-19, JAMA., 10.1001/jama.2020.2783 Letko, 2020, Functional assessment of cell entry and receptor usage for Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage betacoronaviruses, Nat. Microbiol., 10.1038/s41564-020-0688-y Li, 2020, Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia, N. Engl. J. Med., 10.1056/NEJMoa2001316 Lim, 2020, Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR, J. Korean Med. Sci., 35, e79, 10.3346/jkms.2020.35.e79 Lin, 2007, Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine, Antivir. Ther. (Lond.), 12, 1107, 10.1177/135965350701200702 Liu, 2006, Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome, J. Infect. Dis., 193, 792, 10.1086/500469 Luke, 2016, Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo, Sci. Transl. Med., 8, 326ra21, 10.1126/scitranslmed.aaf1061 Martin, 2008, A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial, Vaccine, 26, 6338, 10.1016/j.vaccine.2008.09.026 Mulangu, 2019, A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics, N. Engl. J. Med., 381, 2293, 10.1056/NEJMoa1910993 Pallesen, 2017, Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen, Proc. Natl. Acad. Sci. USA, 114, E7348, 10.1073/pnas.1707304114 Roper, 2009, SARS vaccines: where are we?, Expert Rev. Vaccines, 8, 887, 10.1586/erv.09.43 Sambhara, 2009, Immunosenescence and influenza vaccine efficacy, Curr. Top. Microbiol. Immunol., 333, 413 2020 Sheahan, 2017, Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses, Sci. Transl. Med., 9, 10.1126/scitranslmed.aal3653 Sheahan, 2020, Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV, Nat. Commun., 11, 222, 10.1038/s41467-019-13940-6 2020, The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in China, Zhonghua Liu Xing Bing Xue Za Zhi, 41, 145 Teissier, 2011, Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol, PLoS ONE, 6, e15874, 10.1371/journal.pone.0015874 ter Meulen, 2006, Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants, PLoS Med., 3, e237, 10.1371/journal.pmed.0030237 Tian, 2020, Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody, Emerg. Microbes Infect., 9, 382, 10.1080/22221751.2020.1729069 Tsai, 2013, Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults, Infect. Chemother., 45, 159, 10.3947/ic.2013.45.2.159 Tseng, 2012, Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus, PLoS ONE, 7, e35421, 10.1371/journal.pone.0035421 Wan, 2020, Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS, J. Virol., 10.1128/JVI.00127-20 Wang, 2020, Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, JAMA, 10.1001/jama.2020.1585 Wang, 2016, Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates, ACS Infect. Dis., 2, 361, 10.1021/acsinfecdis.6b00006 Weingartl, 2004, Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets, J. Virol., 78, 12672, 10.1128/JVI.78.22.12672-12676.2004 Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507 Wu, 2020, A new coronavirus associated with human respiratory disease in China, Nature, 579, 265, 10.1038/s41586-020-2008-3 Wu, 2007, Duration of antibody responses after severe acute respiratory syndrome, Emerg. Infect. Dis., 13, 1562, 10.3201/eid1310.070576 Yong, 2019, Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus, Front. Microbiol., 10, 1781, 10.3389/fmicb.2019.01781 Zhang, 2020, Pangolin homology associated with 2019-nCoV, bioRxiv Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Zhou, 2006, A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice, Vaccine, 24, 3624, 10.1016/j.vaccine.2006.01.059 Zhu, 2020, A Novel Coronavirus from Patients with Pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017